Abemaciclib (Verzenio) is a medication in order to treat advanced or metastatic breast cancers. Developed by Eli Lilly, abemaciclib acts as a CDK inhibitor selective for the CDK4 and CDK6.
In the month of October, 2015, abemaciclib was designated as a breakthrough therapy in order to treat breast cancer by the U.S. Food and Drug Administration (FDA).
In the month of July, 2017, thea Food and Drug Administration granted priority review for Lilly's Abemaciclib in order to treat advanced breast cancer.
In the month September, 2017, the Food and Drug Administration approved abemaciclib in order to treat certain advanced or metastatic breast cancers.
In the month of February, 2018, Lilly received the additional Food and Drug Administration approval for abemaciclib as an initial treatment option for advanced breast cancer.
The abemaciclib cost in india is around 246,096 INR for a supply of 14 tablets, depending on the wholesaler/pharmacy you visit. Any WHO-GDP & ISO certified pharmaceutical wholesaler company would be best to buy Abemaciclib.
